2022
DOI: 10.3390/medicina59010057
|View full text |Cite
|
Sign up to set email alerts
|

Different Causes of Functional Tricuspid Valve Regurgitation Are Linked to Differences in Tricuspid Valve and Right-Sided Heart Geometry and Function: 3D Echocardiography Study

Abstract: Background and Objectives: The aim of this study was to clarify the tricuspid valve (TV) and right ventricular (RV) geometry and function characteristics using 3D echocardiography-based analysis and to identify echocardiographic predictors for severe tricuspid regurgitation (TR) in different etiologies of functional TR (fTR). Methods and Results: The prospective study included 128 patients (median age 64 years, 57% females): 109 patients with moderate or severe fTR (69-caused by dominant left-sided valvular pa… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
6
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(6 citation statements)
references
References 28 publications
0
6
0
Order By: Relevance
“…Numerous research has looked into the impact of utilizing various VC width and EROA cutoffs in this setting. They consistently demonstrated a poorer prognosis for patients with either massive or torrential TR 15–18 …”
Section: Discussionmentioning
confidence: 98%
See 4 more Smart Citations
“…Numerous research has looked into the impact of utilizing various VC width and EROA cutoffs in this setting. They consistently demonstrated a poorer prognosis for patients with either massive or torrential TR 15–18 …”
Section: Discussionmentioning
confidence: 98%
“…However, it is critical to understand that PISA may even underestimate how serious TR is, which may account for the persistent rise in mortality linked to EROA >20 mm 2 and regurgitant volume (RegV) >20 mL 14–16 . Another problem is the recently proposed extended grading scheme for TR, which responds to the unmet demand for patient classification, who undergo percutaneous treatment in clinical trials who frequently experience a degree of TR that is more than just serious, whether it be as a result of the extended symptom tolerance or the delayed diagnosis of the illness 17 . Numerous research has looked into the impact of utilizing various VC width and EROA cutoffs in this setting.…”
Section: Discussionmentioning
confidence: 99%
See 3 more Smart Citations